Essex Investment Management CO LLC Tarsus Pharmaceuticals, Inc. Transaction History
Essex Investment Management CO LLC
- $516 Million
- Q4 2024
A detailed history of Essex Investment Management CO LLC transactions in Tarsus Pharmaceuticals, Inc. stock. As of the latest transaction made, Essex Investment Management CO LLC holds 79,760 shares of TARS stock, worth $4.22 Million. This represents 0.86% of its overall portfolio holdings.
Number of Shares
79,760
Previous 109,156
26.93%
Holding current value
$4.22 Million
Previous $3.59 Million
23.01%
% of portfolio
0.86%
Previous 0.67%
Shares
2 transactions
Others Institutions Holding TARS
# of Institutions
178Shares Held
43.5MCall Options Held
484KPut Options Held
4.1K-
Rtw Investments, LP New York, NY3.41MShares$181 Million1.79% of portfolio
-
Black Rock Inc. New York, NY3.27MShares$173 Million0.0% of portfolio
-
Jennison Associates LLC2.5MShares$132 Million0.09% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY2.44MShares$129 Million2.89% of portfolio
-
Tang Capital Management LLC San Diego, CA2.25MShares$119 Million6.32% of portfolio
About Tarsus Pharmaceuticals, Inc.
- Ticker TARS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,658,500
- Market Cap $1.41B
- Description
- Tarsus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutic candidates for ophthalmic conditions. Its lead product candidate is TP-03, a novel therapeutic that is in Phase III for the treatment of blepharitis caused by the infestation of Demodex mites, as well as...